Journal of Medicinal Chemistry · 2008 · 41 citations · 30 references
Life SciencesMedicinal ChemistryPharmacologyCell SignalingDrug DiscoverySignal TransductionCaspase ActivationCytokine BiologyCytokine Receptor SignalingCytokine SignalingSignal Transduction PathwaysBcr-abl InhibitorsHigh-throughput Screening AssaysJak-stat Pathway AntagonismJak-stat Signaling PathwayStat3 Signaling
The JAK-STAT3 pathway regulates genes that are important in cell proliferation and thus is a promising target for cancer therapy. A high-throughput screening (HTS) campaign using an Apo-ONE Homogenous Caspase 3/7 assay in U266 cells identified 4-oxo-1-phenyl-1,4-dihydroquinoline-3-carboxylic acid ethyl ester 4 as a potential STAT3 pathway inhibitor. Optimization of this HTS hit led to the identification of the 7-cyano analogue 8, which inhibited STAT3-Y705 phosphorylation with an EC 50 of 170 nM. Compound 8 also inhibited cytokine induced JAK activation but did not inhibit BCR-ABL activated STAT5 phosphorylation in K562 cells.
30
Jacqueline Bromberg, Melissa H Wrzeszczynska, Geeta Devgan et al. · Cell · 1999 · 2.8K citations · Full text
Stattic: A Small-Molecule Inhibitor of STAT3 Activation and Dimerization
Jochen Schust, Bianca Sperl, Angela Hollis et al. · Chemistry & Biology · 2006 · 1.1K citations
Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor
Naftaly Meydan, T Grunberger, Harjit Dadi et al. · Nature · 1996 · 912 citations